www.abbvie.com Open in urlscan Pro
104.18.35.207  Public Scan

Submitted URL: https://softlifting.ch/
Effective URL: https://www.abbvie.com/
Submission: On October 27 via api from CH — Scanned from CH

Form analysis 1 forms found in the DOM

GET /search-results.html

<form method="get" role="search" class="search-input__form" action="/search-results.html">
  <input class="search-input__input" type="search" autocomplete="off" spellcheck="false" size="10" maxlength="100" aria-label="Search" name="q" data-mobile-placeholder="Search AbbVie.com" data-desktop-placeholder="Search" placeholder="Search">
  <input type="hidden" name="_charset_" value="UTF-8">
</form>

Text Content

Skip to main content
 * Who We Are
    * Our Principles
      Go To Page
       * Positions & Views
   
    * Operating with Integrity
      Go To Page
       * Protecting Human Rights and Workplace Safety
       * Transparency in Payments
       * Responsible Supply Chain
       * AbbVie's Code of Conduct
   
    * Key Facts
    * Our Leaders
    * Policies & Disclosures
    * Our Stories
    * Equity, Equality, Diversity & Inclusion
      Go To Page
       * Impact through Inclusion
       * Commitment to Racial Justice
   
   Close
   
   WHO WE ARE
   
   AbbVie discovers and delivers innovative medicines and solutions that enhance
   people’s lives.
   
   Go To Page
   
    * Positions & Views
    * Explore our history
   
   Quarterly Earnings
   
   ABBVIE REPORTS Q2 2023 FINANCIAL RESULTS
   
   
   
   LATEST EARNINGS RELEASE
   Recognition
   40
   +
   Recognized on great workplace and diversity & inclusion lists
   Back
 * Science
    * Areas of Focus
      Go To Page
       * Immunology
       * Oncology
       * Neuroscience
       * Eye Care
       * Aesthetics
       * Other Specialties
   
    * Areas of Innovation
      Go To Page
       * Data Convergence
       * Genetics & Genomics
       * Patient-Focused Drug Development
       * Precision Medicine
       * Therapeutic Modalities
       * Advanced Technologies
   
    * Pipeline
    * Our R&D Leaders
    * Publications
    * Partner with Us
      Go To Page
       * Partnering Days
       * AbbVie Ventures
   
    * Clinical Trials
      Go To Page
       * Investigator-Initiated Studies
   
    * R&D Sites
    * Independent Educational Grants
      Go To Page
       * How to Apply
       * Request Types
       * Requestor Training Guide
       * Grants and Contribution Disclosures
   
   Close
   
   SCIENCE
   
   We take on the world’s toughest health challenges.
   
   Go to page
    * Pipeline
    * Our R&D Leaders
   
   science
   
   ONCOLOGY
   
   Building on expertise to tackle the toughest cancers.
   
   Learn More
   Innovation
   75
   %
   of our medicines are considered first-in-kind
   Back
 * Patients
    * Patient Support
      Go To Page
       * Patient Assistance
   
    * Product Quality & Safety
    * Products
   
   Close
   
   PATIENTS
   
   We strive to meet patient needs at each step of their health journey.
   
   Go To Page
    * See our Patient Access & Support commitment
    * Learn about our Patient Assistance Programs
   
   October 28, 2021 Patient Support
   
   HOW ABBVIE HELPS PATIENTS ACCESS THEIR PRESCRIBED THERAPIES
   
   3 ways we help people get their medicines
   
   Read Article 6 Minute Read
   Products
   175
   +
   countries where our products help people
   Back
 * Join Us
    * Opportunities
      Go To Page
       * Postdoctoral Program
       * Student Programs
   
    * Life at AbbVie
      Go To Page
       * Benefits 
       * Learning & Development
       * Well-Being in the Workplace
       * Employee Resource Groups
   
    * Why AbbVie
   
   Close
   
   JOIN US
   
   You want to make a difference. We accept that challenge.
   
   Go To Page
    * Search opportunities
    * Benefits 
   
   Join Us
   
   WHY ABBVIE?
   
   Challenging work. Global impact. Every day.
   
   Learn More
   Benefits
   12
   weeks paid leave for U.S. parents welcoming a child
   Back
 * Sustainability
    * Environmental, Social & Governance
    * Philanthropy
      Go To Page
       * Philanthropic Programs
       * Employee Engagement
   
    * Resources
   
   Close
   
   SUSTAINABILITY
   
   Leading with purpose, we are willing to make the tough choices that deliver a
   lasting impact.
   
   Go To Page
    * 2022 ESG Report
    * Environmental, Social & Governance
   
   November 17, 2022 Philanthropy
   
   ABBVIE REBUILDS NORTH CHICAGO’S MIDDLE SCHOOL
   
   Built with AbbVie's $40 million donation, the new Neal Math and Science
   Academy now reflects the talent and potential of its students.
   
   Read Article 5 Minute Read
   Patient access
   190
   K
   U.S. patients provided medicine at no cost in 2022
   Back
 * Quick Links
   Close
   Expand All Collapse All
   
   POPULAR PAGES
   
    * Pipeline
    * Products
    * Partner with Us
    * Patient Support
   
   NEWS CENTER
   
    * Latest News
    * Fact Sheets
    * Media Contacts
   
   INVESTORS
   
    * Investors Home
    * Events and Presentations
    * Investors Resources
   
   EXTERNAL LINKS
   
    * Contract Manufacturing
    * Medical Information
   
   SOCIAL LINKS
   
    * Facebook
    * Twitter
    * Instagram
    * LinkedIn
    * YouTube
   
   Back
 * GLOBAL GLOBAL
   Close
   Expand All Collapse All
   
   AFRICA
   
    * Algeria
    * South Africa and Sub-Saharan Africa
    * Tunisia
   
   ASIA PACIFIC
   
    * Australia
    * China
    * Hong Kong
    * Japan
    * Korea
    * Malaysia
    * New Zealand
    * Singapore
    * Taiwan
   
   EUROPE
   
    * Austria
    * Belgium (French)
    * Belgium (Dutch)
    * Bosnia & Herzegovina
    * Bulgaria
    * Croatia
    * Czech Republic
    * Denmark
    * Finland
    * France
    * Germany
    * Greece
    * Hungary
    * Ireland
    * Italy
    * Netherlands
    * Norway
    * Poland
    * Portugal
    * Romania
    * Russia
    * Serbia
    * Slovakia
    * Slovenia
    * Spain
    * Sweden
    * Switzerland (German)
    * Switzerland (French)
    * Turkey
    * Ukraine
    * United Kingdom
   
   LATIN AMERICA / CARIBBEAN
   
    * Mexico
    * Puerto Rico
   
   MIDDLE EAST
   
    * Israel
    * Lebanon
    * Saudi Arabia
    * United Arab Emirates
   
   NORTH AMERICA
   
    * Canada (English)
    * Canada (French)
    * United States
   
   SOUTH AMERICA
   
    * Argentina
    * Brazil
    * Chile
    * Colombia
    * Uruguay
   
   Back

 * MORE Quick Links
   Close
   Expand All Collapse All
   
   POPULAR PAGES
   
    * Pipeline
    * Products
    * Partner with Us
    * Patient Support
   
   NEWS CENTER
   
    * Latest News
    * Fact Sheets
    * Media Contacts
   
   INVESTORS
   
    * Investors Home
    * Events and Presentations
    * Investors Resources
   
   EXTERNAL LINKS
   
    * Contract Manufacturing
    * Medical Information
   
   SOCIAL LINKS
   
    * Facebook
    * Twitter
    * Instagram
    * LinkedIn
    * YouTube
   
   Back
 * GLOBAL GLOBAL
   Close
   Expand All Collapse All
   
   AFRICA
   
    * Algeria
    * South Africa and Sub-Saharan Africa
    * Tunisia
   
   ASIA PACIFIC
   
    * Australia
    * China
    * Hong Kong
    * Japan
    * Korea
    * Malaysia
    * New Zealand
    * Singapore
    * Taiwan
   
   EUROPE
   
    * Austria
    * Belgium (French)
    * Belgium (Dutch)
    * Bosnia & Herzegovina
    * Bulgaria
    * Croatia
    * Czech Republic
    * Denmark
    * Finland
    * France
    * Germany
    * Greece
    * Hungary
    * Ireland
    * Italy
    * Netherlands
    * Norway
    * Poland
    * Portugal
    * Romania
    * Russia
    * Serbia
    * Slovakia
    * Slovenia
    * Spain
    * Sweden
    * Switzerland (German)
    * Switzerland (French)
    * Turkey
    * Ukraine
    * United Kingdom
   
   LATIN AMERICA / CARIBBEAN
   
    * Mexico
    * Puerto Rico
   
   MIDDLE EAST
   
    * Israel
    * Lebanon
    * Saudi Arabia
    * United Arab Emirates
   
   NORTH AMERICA
   
    * Canada (English)
    * Canada (French)
    * United States
   
   SOUTH AMERICA
   
    * Argentina
    * Brazil
    * Chile
    * Colombia
    * Uruguay
   
   Back
 * Close
   
   --------------------------------------------------------------------------------
   
   
   
   --------------------------------------------------------------------------------

Video Player is loading.
Play Video
Pause
Unmute

Current Time 0:04
/
Duration 0:20
Loaded: 100.00%


0:04
Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -0:16
 
1x
Playback Rate

Chapters
 * Chapters

Descriptions
 * descriptions off, selected

Quality Levels
 * 1080p1080pHD
 * 900p900pHD
 * 720p7, selectedHD
 * 432p432p
 * 288p288p
 * 180p180p
 * AutoAuto

Captions
 * captions settings, opens captions settings dialog
 * captions off, selected

Audio Track
 * en (Main), selected

This is a modal window.


NO VIDEO HAS BEEN LOADED

Error Code: PLAYER_ERR_NO_SRC
Session ID: 2023-10-27:e83180eb9ee88e728f63afc Player Element ID: vjs_video_3
OK
Close Modal Dialog

Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or
activating the close button.






WE FIND ANSWERS THAT MAKE LIFE BETTER FOR PATIENTS AND OUR WORLD.

Learn more


MEETING THE NEEDS OF PATIENTS—AND THE NEEDS OF OUR TIME.

Learn more


IT’S MORE THAN WHAT WE DISCOVER. IT’S HOW WE DELIVER.

Learn more


PUTTING SCIENCE TO WORK TO SOLVE THE CHALLENGES PEOPLE FACE EVERY DAY.

Learn more

Press Releases

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

October 24, 2023

Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3
Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines

October 19, 2023

Allergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast
Reconstruction Patients Through The Reblossom Project

October 15, 2023

AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head
Study in Crohn's Disease Meets All Primary and Secondary Endpoints


Featured

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

August 31, 2023 Oncology

THEN AND NOW: A RENAISSANCE IN BLOOD CANCER TREATMENT

See how scientists have nearly doubled some survival rates, and why we’re not
done yet.

Read Article 5 Minute Read

--------------------------------------------------------------------------------

Science & Innovation

We solve the tough challenges.

By working closely with patients and physicians, we solve the real, complex
challenges they’re facing right now, first with science and support.

R&D

OUR SCIENCE: FIRST, FASTER, AND FOR PATIENTS

At AbbVie, our R&D teams are chasing bold goals.

Learn More
impact
75
+
conditions treated
investment
$7.1
b
R&D investment in 2022
Investing in Science.
Innovating for Patients.



Tenacity is the anchor of solving any real challenge. It's what keeps you there,
keeps you trying, keeps you driven to find that answer.

Bryan Hall
IT manager, AbbVie


--------------------------------------------------------------------------------

a culture of curiosity

We find the answers together.


We make investments that empower our people and strengthen our partnerships.

We are recognized on a number of “Best of” lists related to diversity,
leadership and engagement, as well as for corporate responsibility practices.

OUR LATEST RANKINGS

Grow and fulfill your unique potential in our supportive environment that
champions collaboration. AbbVie offers functional training, global events,
leadership programs and more.

Learning and Development

250+ active external innovation partners to conduct groundbreaking science to
discover and develop transformational medicines.

Partnerships

--------------------------------------------------------------------------------

EXPLORE OPPORTUNITIES

If you thrive as part of a diverse, collaborative team—we’re ready for you. 


Browse jobs

--------------------------------------------------------------------------------

INVESTOR RESOURCES

We invest in creating better futures.


Our focus and capabilities address tough challenges that lead to improved lives.

Quarterly Earnings

ABBVIE REPORTS Q2 2023 FINANCIAL RESULTS



LATEST EARNINGS RELEASE
investor resources

GET THE LATEST INFORMATION ABOUT ABBVIE

Events and presentations Stakeholders contacts Annual report

--------------------------------------------------------------------------------

ENVIRONMENTAL, SOCIAL AND GOVERNANCE

We make an impact that lasts.

Leading with purpose, we are willing to make the tough choices that deliver a
lasting impact to patients, their families and our employees.

--------------------------------------------------------------------------------

Environmental Stewardship
20
%
reduction in Hazardous & Non-Hazardous waste ahead of our 2024 target
SUSTAINABILITY

ENVIRONMENTAL, SOCIAL & GOVERNANCE

See how we're creating positive impact for generations to come.

Learn More
Quick Links

ABBVIE’S POSITIONS & VIEWS

Our Environmental Stewardship Pricing and Access of Our Innovative Medicines
AbbVie's Code of Conduct

--------------------------------------------------------------------------------

 * Who We Are
 * Science
 * Patients
 * Join Us
 * Sustainability

Popular pages
 * Pipeline
 * Products
 * Partner with Us
 * Patient Support

External links
 * News Center
 * Investors
 * Contract Manufacturing
 * Medical Information

--------------------------------------------------------------------------------

Unless otherwise specified, all product names appearing in this internet site
are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or
affiliates. No use of any AbbVie trademark, trade name, or trade dress in this
site may be made without the prior written authorization of AbbVie Inc., except
to identify the product or services of the company.

Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

 * Contact Us
 * Accessibility Statement
 * Site Map
 * Terms of Use
 * Privacy Notice
 * Cookies Settings
 * Your Privacy Choices

 * 
 * 
 * 
 * 
 * 

CLOSE

YOU ARE ABOUT TO LEAVE THE ABBVIE WEBSITE

The product-specific site Internet site that you have requested is intended for
the residents of a particular country or countries, as noted on that site. As a
result, the site may contain information on pharmaceuticals that are not
approved in other countries or region. If you are a resident of a country other
than those to which the site is directed, please return to AbbVie.com or contact
your local AbbVie affiliate to obtain the appropriate product information for
your country of residence. The Internet site that you have requested may not be
optimized to your screen size. Do you wish to continue to this product-specific
site?

No, I disagree
Yes, I agree




This site uses online tracking technologies such as cookies to personalize
content, save your preferences, provide social media features, enable
personalized advertising and track the site’s performance as described in our
Privacy Notice. Please click on Cookies Settings below to manage your
preferences.




Cookies Settings Reject All Accept All Cookies



PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience.

You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.
More information
Accept All Cookies


MANAGE COOKIE SETTINGS

REQUIRED COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy or language preferences, logging in or filling in forms. You can set
your browser to block or alert you about these cookies, but some parts of the
site will not work.

View Vendor Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
If you do not allow these cookies we will not be able to monitor our site’s
performance or learn how to make it better but the site will still work.

View Vendor Details‎

ADVERTISING COOKIES

Advertising Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎

ANONYMOUS PERFORMANCE COOKIES

Anonymous Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
All information these cookies collect is aggregated and therefore anonymous. If
you do not allow these cookies we will not be able to monitor our site’s
performance or learn how to make it better.

View Vendor Details‎
Back Button


VENDORS LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices